Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0169243 STICK-SHAPED BASE MATERIAL COMPRISING LIPID PEPTIDE COMPOUND
A solid base material for external use on skin usable as a stick-shaped base material or similar, and has excellent thermal stability and a breaking strength...
2018/0169242 PHARMACEUTICAL COMBINATION FOR CANCER TREATMENT AND THE THERAPEUTIC USE THEREOF
A pharmaceutical combination for sensitizing a subject to a cancer treatment comprises an amount of metformin and an amount of statin. The amount of metformin...
2018/0169241 ARMED ONCOLYTIC VIRUSES
Disclosed are oncolytic viruses comprising chimeric human/mouse CD40 ligands. The chimeric human/mouse CD40 ligand may be MEM40. The oncolytic virus may be...
2018/0169240 METHODS OF TREATING AUTOIMMUNE AND ALLOIMMUNE DISORDERS
The present disclosure provides methods of treating an alloimmune or autoimmune disorder in an individual; the methods involve administering to the individual...
2018/0169239 METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
The present disclosure provides methods comprising administering to the individual an effective amount of an agent that decreases or inhibits TIGIT expression...
2018/0169238 ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF
Anti-PVRIG and anti-TIGIT antibodies are provided.
2018/0169237 GPC3-TARGETING THERAPEUTIC AGENT WHICH IS ADMINISTERED TO PATIENT FOR WHOM THE GPC3-TARGETING THERAPEUTIC AGENT...
The present invention provides a method for determining the efficacy of a GPC3-targeting therapeutic agent for a liver cancer patient and a GPC3-targeting...
2018/0169236 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy
The invention relates to the identification of gene products that are the result of tumor-associated expression and the nucleic acids encoding the same. The...
2018/0169235 TREATMENT FOR BONE DISEASES
The invention relates to the treatment of bone disorders. In particular, the invention is directed to the use of a dosing holiday to help overcome the...
2018/0169234 Method of Treating Alvelor Bone Loss Through The Use of Anti-Sclerostin Antibodies
The invention provides a method of treating alveolar bone loss involving administration of a sclerostin inhibitor to a subject in need thereof.
2018/0169233 ANTIBODIES AGAINST LIF AND USES THEREOF
Described herein are antibodies that target Leukemia Inhibitory Factor (LIF). Also described herein are uses of these antibodies for the treatment of cancer.
2018/0169232 PD-L1 Antagonist Combination Treatments
The present disclosure describes combination therapies comprising an antagonist of Programmed Death Ligand 1 receptor (PD-L1) and another therapeutic agent,...
2018/0169231 TREATMENT OF OVARIAN CANCER IN PATIENTS WITH ASCITES USING A SPECIFIC BINDING AGENT OF HUMAN ANGIOPOIETIN-2 IN...
Methods and compositions for treating ovarian cancer in a human patient with ascites by administering a therapeutically effective amount of an Ang2 inhibitor...
2018/0169230 COMBINATION CANCER THERAPIES
The disclosure provides methods of treatment for cancer in patients using bispecific anti-IGF-1R, anti-ErbB3 antibodies in combination with one or more...
2018/0169229 COMBINATION OF A PD-1 ANTAGONIST AND CPG-C TYPE OLIGONUCLEOTIDE FOR TREATING CANCER
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a Toll-like receptor 9 (TLR9) agonist...
2018/0169228 ANTI-VEGF ANTIBODY
The present invention relates to antibodies which specifically bind vascular endothelial growth factor (VEGF), in particular heavy-chain antibodies, and more...
2018/0169227 IMMUNITY INDUCTION PROMOTING COMPOSITION, AND VACCINE PHARMACEUTICAL COMPOSITION
The present invention provides an immunity induction-promoting composition which has a track record of use as a medicine or medicinal additive and is capable...
2018/0169226 Vaccine Composition Containing Synthetic Adjuvant
Compositions and methods, including vaccines and pharmaceutical compositions for inducing or enhancing an immune response are disclosed based on the discovery...
2018/0169225 METHODS FOR PREPARING SQUALENE
An improved method for preparing squalene from a squalene-containing composition, said method comprising the steps of (a) a purification distillation carried...
2018/0169224 TLR AGONISTS FOR REDUCING ACTIVATION-INDUCED PD-1 EXPRESSION ON T CELLS AND METHODS OF USE
The present invention is directed toward methods of increasing the immune response to an antigen using TLR1/2 agonist and/or TLR7 agonist in combination with a...
2018/0169223 Vaccine adjuvant composition comprising inulin particles
The present invention provides a pharmaceutically acceptable composition comprising: particles of inulin; a substance comprising or consisting of one or more...
2018/0169222 METHODS AND COMPOSITIONS FOR STIMULATING IMMUNE RESPONSE USING POTENT IMMUNOSTIMULATORY RNA MOTIFS
The presently disclosed subject matter relates to methods and compositions relating to immunostimulatory RNA motifs that act as adjuvants and/or...
2018/0169221 Methods for Enhancing Antigen-Specific Immune Responses
Described herein are methods comprising administering to a mammalian subject an effective amount of an annexin chimeric fusion protein, wherein the annexin...
2018/0169220 ALLERGY-SPECIFIC IMMUNOTHERAPY COMPOSITIONS FOR USE IN THE TREATMENT OF HOUSE-DUST MITE ALLERGY
The present invention relates to a composition comprising purified natural Der p1 and purified natural Der p2 allergens for use in the treatment of house-dust...
2018/0169219 HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF
The present disclosure provides heterodimeric polypeptides comprising: 1) a variant hepatitis C virus (HCV) E2 polypeptide and an HCV E1 polypeptide; 2) a...
2018/0169218 NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL...
The present invention relates to a nucleic acid sequence, comprising or coding for a coding region, encoding at least one peptide or protein comprising a...
2018/0169217 MATERIALS AND METHODS FOR RESPIRATORY DISEASE CONTROL IN CANINES
The subject invention pertains to isolated influenza virus that is capable of infecting canids and causing respiratory disease in the canid. The subject...
2018/0169216 FMDV and E2 Fusion Proteins and Uses Thereof
The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The...
2018/0169215 Multivalent Enterovirus Vaccine Compositions and Uses Related Thereto
This disclosure relates to multivalent enterovirus vaccine compositions and uses related thereto. In certain embodiments, the disclosure relates to vaccine...
2018/0169214 PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
An improved method for recovering the protein expressed by open reading frame 2 from porcine circovirus type 2 is provided. The method generally involves the...
2018/0169212 GLYCOSYLATION METHOD
The invention relates to microbial host cells engineered to produce glycoconjugate vaccines by stable integration of an acceptor protein and an...
2018/0169211 Peptides derived from acinetobacter baumannii and their use in vaccination
The present invention relates to proteins derived from Acinetobacter Baumanii, nucleic acids encoding the proteins, antibodies specific for the proteins as...
2018/0169210 HYBRID AND TANDEM EXPRESSION OF NEISSERIAL PROTEINS
Two or more Neisserial proteins are joined such that they are translated as a single polypeptide chain. Hybrid proteins are represented by the formula...
2018/0169209 FSBM Recombinant Protein
The invention discloses a FSBM recombinant protein for conferring protection against group C streptococcus infection in an animal subject, comprising: a first...
2018/0169208 PROTECTIVE ANTIGEN COMPLEXES WITH INCREASED STABILITY AND USES THEREOF
Immunogenic compositions against Bacillus anthracis comprising a stabilized protective antigen complex are disclosed. The stabilized complex comprises...
2018/0169207 REMEDY FOR BOVINE LEUKEMIA PROPHYLAXIS AND USE THEREOF
The invention generally relates to the field of veterinary medicine and can be used for bovine leukemia prevention. The invention expands the range of means of...
2018/0169206 Immunogenic compositions
This invention relates to immunogenic compositions, particularly vaccine compositions, for use in providing protection against illness caused by bacterial...
2018/0169205 HYBRID FLAGELLIN AS A T CELL INDEPENDENT VACCINE SCAFFOLD
A method of immunizing a subject. The method includes administering to the subject an immunogenic amount of a filament including one or more hybrid flagellin...
2018/0169204 COMBINATION VACCINES WITH LOWER DOSES OF ANTIGEN AND/OR ADJUVANT
Combination vaccine compositions as well as methods for their manufacture have a relatively low amount of antigen and/or a relatively low amount of aluminium,...
2018/0169203 PARTNER OF SLD FIVE 1 (PSF1)-DERIVED PEPTIDE
A Partner of Sld Five 1 (PSF1)-derived peptide that can induce a Cytotoxic T-Cell (CTL) response useful for a specific immunotherapy for cancer patients and a...
2018/0169202 COMBINATION OF VACCINATION AND INHIBITION OF THE PD-1 PATHWAY
The present invention relates to a vaccine/inhibitor combination comprising an RNA vaccine comprising at least one RNA comprising at least one open reading...
2018/0169201 COMBINATION OF VACCINATION AND INHIBITION OF THE PD-1 PATHWAY
The present invention relates to a vaccine/inhibitor combination comprising an RNA vaccine comprising at least one RNA comprising at least one open reading...
2018/0169200 METHOD FOR INDUCING EARLY T MEMORY RESPONSE WITH SHORT PEPTIDES ANTI-TUMOR VACCINE
The present invention relates to a therapeutic peptide T specific immune therapy for use in the treatment of a cancer of an HLA-A2 (Human Leukocyte Antigen A2)...
2018/0169199 HSP70-Derived Peptide, Pharmaceutical Composition for Treating or Preventing Cancer Using Same, Immunity...
The present invention provides a peptide containing 8 or more consecutive amino acid residues in an amino acid sequence of any of SEQ ID NOS: 1 to 15 and...
2018/0169198 COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES TO EIMERIA OR LIMITING EIMERIA INFECTION
Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality...
2018/0169197 AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE
There is provided a method for treating or reducing the effects of fructose intolerance and health problems associated with excessive fructose intake by...
2018/0169196 PURIFICATION AND ISOLATION OF RECOMBINANT OXALATE DEGRADING ENZYMES AND SPRAY-DRIED PARTICLES CONTAINING...
The present invention comprises methods and compositions for the reduction of oxalate in humans, and methods for the purification and isolation of recombinant...
2018/0169195 METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
A method of treating a subject having or at risk for having a virus infection, by administering to the subject a therapeutically effective amount of a...
2018/0169194 METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
A method of treating a subject having a retroviral infection, by administering to the subject a therapeutically effective amount of a composition comprising a...
2018/0169193 METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
Methods of inactivating a proviral DNA genome or a DNA genome integrated into the genome of a host cell latently infected with a retrovirus, by treating the...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.